Risk assessment and risk treatment
Assign topic to the user
Answer: All our templates from our ISO 27001 Toolkits, including the templates for risk assessment and risk treatment, are fully compliant with requirements of ISO 27001.
At this link you can see all templates that cover the risks assessment and risk treatment process: https://advisera.com/27001academy/iso-27001-22301-risk-assessment-toolkit/ :
- Risk Assessment and Risk Treatment Methodology
- Risk Assessment Table
- Risk Treatment Table
- Risk Assessment and Treatment Report
- Statement of Applicability
- Risk Treatment Plan
On the links for the individual templates you can see which requirements are covered by each document. For example, the Risk Assessment and Risk Treatment Methodology (https://advisera.com/27001academy/documentation/Risk-Assessment-and-Risk-Treatment-Methodology/) cover the following requirements: ISO/IEC 27001 6.1.2, 6.1.3, 8.2, and 8.3; ISO 22301 8.2.1, 8.2.3.
2. What precautions should be taken to avoid getting Non Conformity on this?
Answer: Key points to pay attention when performing risk assessment and risk treatment are to consider the proper inputs (e.g., legal requirements, scope and policy, etc.), so you do not leave any relevant area of your system uncovered, to cover all the assets in the ISMS scope during the risk assessment (if you decide to use the asset-based approach), and to ensure your risk evaluation and treatment options are aligned with your risk acceptance criteria.
This article will provide you further explanation about risk assessment and risk treatment:
- ISO 27001 risk assessment & treatment – 6 basic steps https://advisera.com/27001academy/knowledgebase/iso-27001-risk-assessment-treatment-6-basic-steps/
This material will also help you regarding risk assessment and risk treatment:
- The basics of risk assessment and treatment according to ISO 27001 [free webinar] https://advisera.com/27001academy/webinar/basics-risk-assessment-treatment-according-iso-27001-free-webinar-demand/
Comment as guest or Sign in
Mar 02, 2019